Warmuth Markus

Warmuth Markus is listed in filings as President & CEO at Monte Rosa Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Monte Rosa Therapeutics, Inc. (GLUE). The current snapshot covers public activity from Jan 6, 2025 to Jun 2, 2026. Reported amounts are shown as $97.0K to $103.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.